Epoch Investment Partners Inc. Acquires 155,235 Shares of Waters Co. (NYSE:WAT)

Epoch Investment Partners Inc. raised its holdings in shares of Waters Co. (NYSE:WATFree Report) by 148.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 259,691 shares of the medical instruments supplier’s stock after purchasing an additional 155,235 shares during the quarter. Epoch Investment Partners Inc. owned 0.44% of Waters worth $85,498,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Annis Gardner Whiting Capital Advisors LLC bought a new stake in Waters during the 3rd quarter valued at $33,000. Exchange Traded Concepts LLC bought a new stake in Waters during the 4th quarter valued at $35,000. VisionPoint Advisory Group LLC grew its stake in shares of Waters by 300.0% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 144 shares of the medical instruments supplier’s stock worth $39,000 after acquiring an additional 108 shares in the last quarter. Wetzel Investment Advisors Inc. bought a new stake in shares of Waters in the 4th quarter worth $39,000. Finally, Turtle Creek Wealth Advisors LLC bought a new stake in shares of Waters in the 4th quarter worth $41,000. Institutional investors own 94.01% of the company’s stock.

Waters Stock Performance

NYSE WAT traded up $1.54 during trading on Friday, hitting $302.09. 453,576 shares of the company’s stock traded hands, compared to its average volume of 518,595. The stock has a market capitalization of $17.92 billion, a price-to-earnings ratio of 29.65, a PEG ratio of 4.79 and a beta of 0.97. Waters Co. has a 12-month low of $231.90 and a 12-month high of $367.21. The company has a debt-to-equity ratio of 1.60, a quick ratio of 1.30 and a current ratio of 1.94. The business has a 50 day moving average of $327.55 and a 200-day moving average of $322.57.

Waters (NYSE:WATGet Free Report) last released its quarterly earnings data on Tuesday, May 7th. The medical instruments supplier reported $2.21 EPS for the quarter, beating the consensus estimate of $2.10 by $0.11. The business had revenue of $636.80 million for the quarter, compared to the consensus estimate of $635.57 million. Waters had a net margin of 20.75% and a return on equity of 66.59%. The company’s revenue was down 7.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.49 earnings per share. As a group, equities research analysts anticipate that Waters Co. will post 11.85 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently issued reports on WAT shares. Evercore ISI upped their target price on shares of Waters from $320.00 to $340.00 and gave the stock an “in-line” rating in a research note on Thursday, April 4th. Barclays reduced their price target on shares of Waters from $300.00 to $295.00 and set an “underweight” rating for the company in a research report on Wednesday, May 8th. Jefferies Financial Group started coverage on shares of Waters in a research report on Monday, June 3rd. They set a “hold” rating and a $320.00 price target for the company. TD Cowen increased their price target on shares of Waters from $350.00 to $358.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th. Finally, Stifel Nicolaus increased their price target on shares of Waters from $330.00 to $332.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th. One equities research analyst has rated the stock with a sell rating and eleven have issued a hold rating to the company’s stock. According to MarketBeat.com, Waters currently has an average rating of “Hold” and an average target price of $307.20.

View Our Latest Stock Report on Waters

Insider Transactions at Waters

In other news, Director Christopher A. Kuebler sold 4,000 shares of the stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $361.64, for a total value of $1,446,560.00. Following the sale, the director now directly owns 14,716 shares of the company’s stock, valued at $5,321,894.24. The sale was disclosed in a legal filing with the SEC, which is available at this link. In related news, Director Richard H. Fearon acquired 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 28th. The shares were bought at an average cost of $332.90 per share, for a total transaction of $332,900.00. Following the completion of the transaction, the director now owns 1,653 shares in the company, valued at $550,283.70. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Christopher A. Kuebler sold 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $361.64, for a total transaction of $1,446,560.00. Following the completion of the transaction, the director now owns 14,716 shares in the company, valued at $5,321,894.24. The disclosure for this sale can be found here. Insiders own 0.82% of the company’s stock.

Waters Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Read More

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.